Stephen Mandel Forma Therapeutics Holdings, Inc. Transaction History

Lone Pine Capital LLC

  • $12.7 Billion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$13.6 - $24.89 $10.9 Million - $19.9 Million
-800,000 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$34.9 - $51.08 $27.9 Million - $40.9 Million
800,000 New
800,000 $27.9 Million

Others Institutions Holding FMTX

# of Institutions
2
Shares Held
26.5K
Call Options Held
0
Put Options Held
0
View Full List

About Forma Therapeutics Holdings, Inc.

FMTX Quotes by TradingView
  • Ticker FMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,860,400
  • Market Cap $958M
  • Description
  • Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...
More about FMTX
Track Stephen Mandel's Portfolio

Track Stephen Mandel Portfolio

Follow Stephen Mandel (Lone Pine Capital LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lone Pine Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lone Pine Capital LLC and Stephen Mandel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email